Product Overview
OXYMED LA is a veterinary medicinal product containing oxytetracycline (as dihydrate) at a concentration of 200 mg/ml. It is formulated as a solution for injection for cattle and sheep and is administered by deep intramuscular injection as a single dose.
Indications for Use
OXYMED LA acts as a bacteriostatic agent against a range of Gram-positive and Gram-negative organisms, as well as certain other microorganisms sensitive to oxytetracycline.
Gram-positive organisms
Staphylococcus spp., Streptococcus spp., Bacillus anthracis, Clostridium spp., Erysipelothrix rhusiopathiae, Listeria monocytogenes and Corynebacterium spp.
Gram-negative organisms
Pasteurella spp., Bordetella bronchiseptica, Actinobacillus spp., Klebsiella spp., Fusobacterium necrophorum, Haemophilus spp. and Bacteroides spp.
Certain mycoplasmas, rickettsiae, protozoa, spirochetes and chlamydiae may also be sensitive to oxytetracycline. Microorganisms with a minimum inhibitory concentration (MIC) of less than 4 µg/ml are considered sensitive to oxytetracycline.
General indications
Treatment of infections in cattle and sheep caused by organisms sensitive to oxytetracycline, including arthritis, gastrointestinal and respiratory infections associated with susceptible microorganisms such as:
Bordetella spp., Campylobacter spp., Chlamydia spp., Escherichia coli, Haemophilus spp., Mycoplasma spp., Pasteurella spp., Rickettsia spp., Salmonella spp., Staphylococcus spp. and Streptococcus spp.
Cattle
- Treatment and control of respiratory infections due to Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Mycoplasma spp. and other organisms sensitive to oxytetracycline.
- Treatment of bovine infectious keratoconjunctivitis (pinkeye) caused by Moraxella bovis.
Sheep
- Treatment of foot rot disease caused by oxytetracycline- sensitive strains of Dichelobacter nodosus and Fusobacterium species.
Dosage and Administration
Route of administration: Deep intramuscular injection.
Dosage: 20 mg oxytetracycline per kg body weight.
Cattle
10 ml of OXYMED LA per 100 kg body weight, administered by deep intramuscular injection.
Maximum recommended volume at one injection site: 10 ml.
Sheep
1 ml of OXYMED LA per 10 kg body weight, administered intramuscularly in the neck.
Maximum recommended volume at one injection site: 5 ml.
Withdrawal Periods
Use During Pregnancy and Lactation
Although oxytetracycline does not have genotoxic, embryotoxic or foetotoxic effects, it is known to cross the placental barrier and deposit in the teeth and bones of the foetus and newborn animal.
Therefore, use of this antibiotic during pregnancy should be based on a risk/benefit assessment made by the responsible veterinarian.
The same principle applies to administration in lactating animals during the nursing phase with suckling offspring.
This product may be used in lactating cows with consideration of the applicable milk withdrawal period.
Storage and Shelf Life
Packaging
Glass vial: 1 × 100 ml, packed in a cardboard box.
Product Classification
Prescription-only veterinary medicine.
Manufacturer
AVE & VETMEDIC DOO
Production Site:
Bregalnicka 32, 26300 Vršac, Republic of Serbia
Head Office:
Petra Lekovica 6, 11000 Belgrade, Republic of Serbia
Exclusive Agency and Distribution in Iran
FAAM ZARIN KIMIA AVAR COMPANY
Responsible for exclusive agency rights, marketing, distribution and importing in Iran.
Unit 2 (West), No. 458, Jamalzadeh Shomali, Tehran, Iran.